Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Clinical trial NCT00083161 · COMPLETED
Trial details
- NCT number
- NCT00083161
- Sponsor
- Gundersen Lutheran Health System
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Primary completion
- 2010-05-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.